Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 |
Revenues | 27.0 | 13.7 | 9.0 | 3.4 | 2.4 |
Revenue growth | 96.9% | 52.5% | 162.5% | 43.0% | |
Cost of goods sold | -39.2 | -22.2 | -17.8 | -3.1 | -3.2 |
Gross profit | 66.2 | 35.9 | 26.8 | 6.5 | 5.6 |
Gross margin | 245.1% | 262.0% | 297.6% | 189.5% | 234.1% |
Research and development | 27.0 | 12.8 | 8.1 | 2.6 | 2.4 |
General and administrative | 6.1 | 5.2 | 5.3 | 0.6 | 0.4 |
EBIT | 33.1 | 18.0 | 13.4 | 3.2 | 2.8 |
EBIT margin | 122.5% | 131.0% | 148.8% | 94.7% | 117.0% |
Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|